相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study of ACE-011 (ActRIIA-IgG1) in Postmenopausal Women
Jon Ruckle et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling
Nadeem Samee et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
The β1 integrin activates JNK independent of CagA, and JNK activation is required for Helicobacter pylori CagA+-induced motility of gastric cancer cells
Jared L. Snider et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A soluble activin type IIA receptor induces bone formation and improves skeletal integrity
R. Scott Pearsall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo
Claire M. Edwards et al.
BLOOD (2008)
BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors
George P. Allendorph et al.
BIOCHEMISTRY (2007)
Neutralizing B-cell-activating factor antibody improves survival and inhibits osteoclastogenesis in a severe combined Immunodeficient human multiple myeloma model
Paola Neri et al.
CLINICAL CANCER RESEARCH (2007)
The activin A-follistatin system: potent regulator of human extracellular matrix mineralization
Marco Eijken et al.
FASEB JOURNAL (2007)
Changes in extracellular activin A: follistatin ratio during differentiation of a mesenchymal progenitor cell line, ROB-C26 into osteoblasts and adipocytes
Niki Kawabata et al.
LIFE SCIENCES (2007)
Inhibin A is an endocrine stimulator of bone mass and strength
Daniel S. Perrien et al.
ENDOCRINOLOGY (2007)
TGF-beta promotes the establishment of renal cell carcinoma bone metastasis
Scott L. Kominsky et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
New potential targets for treating myeloma bone disease
G. David Roodman
CLINICAL CANCER RESEARCH (2006)
A clinically relevant SCID-hu in vivo model of human multiple myeloma
P Tassone et al.
BLOOD (2005)
Regulation of osteoblastogenesis and bone mass by Wnt10b
CN Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system
E del Re et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
E Tian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-β1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression
MH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Calcium-regulated expression of activin A in RBL-2H3 mast cells
M Funaba et al.
CELLULAR SIGNALLING (2003)
BMP signals regulate Dlx5 during early avian skull development
N Holleville et al.
DEVELOPMENTAL BIOLOGY (2003)
Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures
D Gaddy-Kurten et al.
ENDOCRINOLOGY (2002)
Antisense inhibition of macrophage inflammatory protein 1-α blocks bone destruction in a model of myeloma bone disease
SJ Choi et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
TGF-β signaling in tumor suppression and cancer progression
R Derynck et al.
NATURE GENETICS (2001)
Activin A is an essential cofactor for osteoclast induction
K Fuller et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
